Coronavirus: Commission completes vaccines portfolio following talks with a sixth manufacturer

Sep 08, 2020

European Commission Press release Brussels, 09 Sep 2020 The European Commission has today concluded exploratory talks with BioNTech-Pfizer to purchase a potential vaccine against COVID-19.


Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies.